M. Ya. Ruda

Superiority of ibutilide (a new class III agent) overdl-sotalol in converting atrial flutter and atrial fibrillation

Marc A. Vos, Golitsyn Sp, Karl Stangl et al. · Heart · 1998 · 199 citations · Full text

Synthesis of some hydroxynaphthazarins and their cardioprotective effects under ischemia-reperfusion in vivo

Victor Ph. Anufriey, O.B. Maximov, G. B. Elyakov et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 74 citations

Biochemistry, Reperfusion Injury, Medicine +7

Protection of ischemic myocardium by exogenous phosphocreatine (Neoton): Pharmacokinetics of phosphocreatine, reduction of infarct size, stabilization of sarcolemma of ischemic cardiomyocytes, and antithrombotic action

Victor G. Sharov, N. I. Afonskaya, M. Ya. Ruda et al. · Biochemical Medicine and Metabolic Biology · 1986 · 46 citations

Thrombosis, Ischemic Myocardium, Heart Failure +12

Efficacy of Azimilide for the Maintenance of Sinus Rhythm in Patients With Paroxysmal Atrial Fibrillation in the Presence and Absence of Structural Heart Disease

Charles R. Kerr, Stuart J. Connolly, Peter R. Kowey et al. · The American Journal of Cardiology · 2006 · 34 citations

Thrombosis, Cardiac Anaesthesia, Structural Heart Disease +12

ACUTE ST ELEVATION MYOCARDIAL INFARCTION: AFTERCARE AND SECONDARY PREVENTION. NATIONAL RUSSIAN GUIDELINES

Artem Doletsky, V. B. Krasnitsky, N. P. Lyamina et al. · Russian Journal of Cardiology · 2015 · 34 citations · Full text